价格

T-02

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

T CELL RECEPTORS
- EP 3642224 B1
  申请人: IMMUNOCORE LTD优先权: 2017
  CN
  EP
  US
  WO
  13 件公开
- EP 3433270 B1
  申请人: IMMUNOCORE LTD优先权: 2016
  CN
  EP
  US
  WO
  7 件公开
- US 11505590 B2
  申请人: IMMUNOCORE LTD优先权: 2016
  CN
  EP
  US
  WO
  7 件公开
- US 11203627 B2
  申请人: ADAPTIMMUNE LTD优先权: 2014
  CN
  US
  2 件公开
- WO 2026125734 A1
  申请人: ETCEMBLY LTD优先权: 2024
  WO
CAR FOR USE IN THE TREATMENT OF HVG DISEASE
EP 3946636 B1申请人: MEDIZINISCHE HOCHSCHULE HANNOVER优先权: 2019
CN
EP
US
WO
8 件公开
FUSION PROTEIN FOR USE IN THE TREATMENT OF HVG DISEASE
EP 3263595 A1申请人: MEDIZINISCHE HOCHSCHULE HANNOVER优先权: 2016
CN
EP
US
6 件公开
T CELL RECEPTORS SPECIFIC FOR THE NY-ESO-1 TUMOR ANTIGEN-HLA-A*02 COMPLEX
EP 3394094 B1申请人: IMMUNOCORE LTD优先权: 2015
CN
EP
US
WO
5 件公开
CD5 specific T cell receptor cell or gene therapy
US 12479903 B2申请人: MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT优先权: 2019
EP
US
WO
5 件公开
HUMAN T CELL RECEPTOR PAIRS REACTIVE WITH HLA-A*02:01 RESTRICTED HUMAN PROSTATIC ACID PHOSPHATASE (PAP) EPITOPES
EP 4486768 A4申请人: UNIV CALIFORNIA优先权: 2022
CN
EP
US
WO
4 件公开
T CELL RECEPTOR
EP 4634215 A1申请人: ADAPTIMMUNE LTD优先权: 2022
CN
EP
US
WO
4 件公开
MAGE-B2-SPECIFIC T-CELL RECEPTORS
EP 4267173 A2申请人: AMGEN INC优先权: 2020
EP
US
WO
4 件公开
T CELL RECEPTORS AND FUSION PROTEINS THEREOF
US 20240109950 A1申请人: IMMUNOCORE LTD优先权: 2022
CN
US
4 件公开
Specific t cell receptors against epitopes of mutant MYD88L265P protein for adoptive T cell therapy
US 12365717 B2申请人: CHARITE—UNIVERSITAETSMEDIZIN BERLIN优先权: 2019
CN
EP
US
3 件公开

药物

T-02

专利

T CELL RECEPTORS